ReviewFrontiers in immunology2024

Leveraging the synergy between anti-angiogenic therapy and immune checkpoint inhibitors to treat digestive system cancers.

Qinlan Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.